skip to main content
Cargill Logo
Cargill
  • Our Stories
  • About Cargill

    About Cargill

    • Thrive Stories
    • Company Overview
    • Executive Team
    • 2022 Annual Report
    • Our History
    • Community Engagement
    • Research & Development
    • Diversity, Equity and Inclusion
    • Workplace Safety
    • Ethics & Compliance
    • Supplier Central
    • Contact Us
  • Sustainability

    Sustainability

    • Supply Chains
    • Sustainability Priorities
    • 2022 ESG Report
    • Reporting Hub
    • Newsletter signup
    • Innovation that Sustains
  • Products & Services

    Products & Services

    • Agriculture
    • Animal Nutrition
    • Beauty
    • Bioindustrial
    • Foodservice
    • Food & Beverage
    • Industrial
    • Pharmaceutical
    • Meat & Poultry
    • Risk Management
    • Supplements
    • Transportation
  • News

    News

    • All Press Releases
    • Company Statements
    • In The News
  • Careers
  • Worldwide
  • Contact
Home/Products & Services/Pharmaceutical/Pharma Applications/Parenteral applications
  • Pharmaceutical
    • In the spotlight: Changing regulatory requirements in China
    • Pharma Expertise
    • Pharma Applications
      • Solid Dosage Forms
      • Liquid dosage forms
      • Medicated confectionery
      • Oral nutritional supplements
      • Parenteral applications
      • Medical devices
    • Pharma Products
      • Citrates
        • Citric Acid
          • Contact Us
        • Potassium Citrate
        • Sodium Citrate
        • Contact Us
      • Erythritol
      • Pharmaceutical Ethanol
        • 96% Pharmaceutical Agricultural Ethanol
        • 99.9% Pharmaceutical Agricultural Ethanol
        • 96% GMP Pharmaceutical Ethanol
      • Glucose Liquids
      • Glucose Liquids Spray-dried
      • Glucose Monohydrates (Dextrose)
      • Hydrocolloids for Pharma
        • Carrageenans
        • Pectin in Pharma
        • Xanthan Gum
      • Isomalt
      • Lecithins and phospholipids
        • Lecithins
        • Phospholipids
      • Maltitol
      • Maltodextrins
      • Mannitol
      • Sorbitol
      • Starches
    • Contact Cargill about Pharmaceutical ingredients
 
parental applications

Parenteral applications

Parenteral nutrition and injectables dialysis

Parenteral nutrition and intravenous injection are applications requiring products of the highest standards of quality. Our products are manufactured with the same care, control and attention to detail at every stage of the process, and we have invested heavily to ensure all pharmaceutical grade products are all produced in line with appropriate quality management systems. Our ingredients for parenteral applications provide many functionalities including: energy source, osmotic agent, osmotic diuretic, emulsification and solubilization.

The phospholipid phosphatidylcholine has also proven in many studies to have advantageous effects on the liver, even if it has been impaired.*

* All potential health claims are currently subject to final approval by the EFSA.

Energy source for parenteral nutrition

Nutrition is a significant factor in considering ingredients for parenteral applications – a sufficient supply of energy in the immediate post-traumatic or post-operative recovery phase is particularly important for patients.

We manufacture pyrogen-free monohydrous dextrose under the name C* PharmDex™, which meets the highest purity standards. This is achieved by ultrafiltration techniques that prevent endotoxin (pyrogen) contamination and remove any occurring polysaccharides. C* PharmDex™ is ideally suited to parenteral nutrition – it is readily water soluble, is very stable and its and solutions are characterized by excellent filterability. Also available is endotoxin-free mannitol, a reduced calorie nutrient that is used in dialysis and serum applications.

Product Brand Name
Monohydrous dextrose C* PharmDex™

 

Emulsifying agents for parenteral nutrition

Cargill’s phospholipids are excellent emulsifiers for parenteral nutrition and contribute additionally to the energy delivered to the patient.

Product Brand Name
Deoiled phospholipid Epikuron™ 145 V*  
Purified phospholipid Epikuron™ 170*  
Purified phosphatidylcholine Epikuron™ 200*  

* The product serves also as choline source, protects the liver, controls the level of cholesterol and is a source of polyunsaturated fatty acids.

N.B. All potential health claims are currently subject to final approval by the EFSA. 

Osmotic agents

Osmotic agents in injectables and dialysis

The aim of intravenous treatments is to optimize the balance of fluids, energy, nitrogen and electrolytes in the blood by the infusion of appropriate solutions. As with all parenteral applications, ensuring the solution is pyrogen-free is vital.

Our plants operate a dedicated production channel for pharmaceutical-grade dextrose monohydrate and mannitol for intravenous injections. The plant facilities have been audited by most of the producers of solutions of parenteral infusion and hemodialysis worldwide. Cargill was approved as a qualified supplier in all cases.

Product Brand Name
Monohydrouse dextrose C* PharmDex™
Twitter Facebook Linkedin YouTube Instagram
Contact Worldwide
Privacy Notices Fraud Notice
Website Terms of Use Purchase Order Terms
© 2023 Cargill, Incorporated. All Rights Reserved.